Gene · 2189
Papers1,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of Prognosis and Immune Landscapes Based on Lipid-Metabolism- and Ferroptosis-Associated Signature in Uterine Corpus Endometrial Carcinoma. | Diagnostics (Basel) | 2023 | 36900015 | PubTator, text mining | PubMed |
| Implementation of Exome Sequencing in Prenatal Diagnostics: Chances and Challenges. | Diagnostics (Basel) | 2023 | 36900003 | PubTator, text mining | PubMed |
| Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis. | J Med Genet | 2023 | 36894310 | PubTator, text mining | PubMed |
| Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant. | Haematologica | 2023 | 36891729 | PubTator, text mining | PubMed |
Experience of living with multimorbidity and health workers perspectives on the organization of health services for people living with multiple chronic conditions in Bahir Dar, northwest Ethiopia: a qualitative study. | BMC Health Serv Res | 2023 | 36890489 | PubTator, text mining | PubMed |
| Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer. | Cancer Discov | 2023 | 36862804 | PubTator, text mining | PubMed |
| Designing a Novel Monitoring Approach for the Effects of Space Travel on Astronauts' Health. | Life (Basel) | 2023 | 36836933 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches. | J Pers Med | 2023 | 36836518 | PubTator, text mining | PubMed |
| The repertoire of copy number alteration signatures in human cancer. | Brief Bioinform | 2023 | 36806386 | PubTator, text mining | PubMed |
| N-thiocarboxyanhydrides, amino acid-derived enzyme-activated H2S donors, enhance sperm mitochondrial activity in presence and absence of oxidative stress. | BMC Vet Res | 2023 | 36797726 | PubTator, text mining | PubMed |
| Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer. | Cancers (Basel) | 2023 | 36765737 | PubTator, text mining | PubMed |
| BTN2A1-BRAF fusion may be a novel mechanism of resistance to osimertinib in lung adenocarcinoma: a case report. | Transl Cancer Res | 2023 | 36760378 | PubTator, text mining | PubMed |
| Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer. | medRxiv | 2023 | 36747679 | PubTator, text mining | PubMed |
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
| Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study. | Mol Med | 2023 | 36717774 | PubTator, text mining | PubMed |
| A novel RAD51 variant resulting in Fanconi anemia identified in an infant with multiple congenital anomalies. | Clin Case Rep | 2023 | 36698515 | PubTator, text mining | PubMed |
| T-2 toxin-induced intestinal damage with dysregulation of metabolism, redox homeostasis, inflammation, and apoptosis in chicks. | Arch Toxicol | 2023 | 36695871 | PubTator, text mining | PubMed |
| A CRISPR-Cas9 screen identifies EXO1 as a formaldehyde resistance gene. | Nat Commun | 2023 | 36693839 | PubTator, text mining | PubMed |
| Changes in Serum Protein-Peptide Patterns in Atopic Children Allergic to Plant Storage Proteins. | Int J Mol Sci | 2023 | 36675318 | PubTator, text mining | PubMed |
| Aplastic Anemia in Triple X Syndrome. | Children (Basel) | 2023 | 36670650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2189/papers?page=7